| Bioactivity | Antimicrobial agent-35 (Compound c9) exhibits antibacterial agent, that inhibits S. aureus, E. coli, E. faecalis, and S. maltophilia with MIC of 0.5-2 μg/mL. Antimicrobial agent-35 exhibits cytotoxicity against HT-22 with IC50 of 130.4 μg/mL[1]. |
| Formula | C52H73N7O8 |
| Molar Mass | 924.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fan Z, et al., Design, Synthesis, and Activity Evaluation of C-23-Modified 5-O-Mycaminosyltylonolide Derivatives. ACS Med Chem Lett. 2024 Nov 25;15(12):2171-2180. |
Antimicrobial agent-35
CAS: F: C52H73N7O8 W: 924.18
Antimicrobial agent-35 (Compound c9) exhibits antibacterial agent, that inhibits S. aureus, E. coli, E. faecalis, and S.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.